USE OF HYALURONAN-RICH TRANSFER MEDIUM FOR A SINGLE BLASTOCYST TRANSFER IN VITRO FERTILIZATION PROCEDURE
Abstract
Background. The best way to avoid undesirable multiple pregnancies following in vitro fertilization procedure (IVF) is to perform elective single embryo transfer, but the procedure might result in a reduction of the pregnancy rates. Aim of our study was to establish whether a single blastocyst transfer using a hyaluronan rich transfer medium results in higher pregnancy rates in comparison to the transfer using a conventional transfer medium.
Material and methods. Our prospective randomized study included 107 patients enrolled in the 1st, 2nd and 3rd classical IVF or intracytoplasmic sperm injection (ICSI) treatment attempt. Patients included were under 37 years of age with at least one blastocyst developed in the procedure. In the study group (47 patients) blastocyst transfers using the hyaluronan rich transfer medium were performed and in the control group (60 patients) the conventional medium was used. The pregnancy rates in the study and in the control group were compared.
Results. The average pregnancy rate per single blastocyst transfer was 30 %; there were no twin pregnancies. The single blastocyst transfer using hyaluronan resulted in a non-significantly higher pregnancy rate (11 %). A significantly higher pregnancy rate with the use of hyaluronan was found in the subgroup of patients with two or more blastocysts developed in their 2nd and 3rd IVF attempt (p = 0.045).
Conslusions. The single blastocyst transfer results in high implantation rates. Hyaluronan significantly contributes to higher implantation rates in a selected subgroup of patients following previous implantation failure and with multiple blastocysts developed.
Downloads
References
Balaban B, Isiklar A, Yakin, Gursoy H, Urman B. Increased implantation rates in patients with recurrent implantation failures following
the use a new transfer medium enriched with hyaluronan. In: Abstracts of the 20th Annual Meeting of the ESHRE, Berlin, Germany, 27–30
June 2004.
Schoolcraft W, Lane M, Stevens J, Gardner DK. Increased Hyaluronan concentration in the embryo transfer medium results in a significant
increase in human embryo implantation rate. Fertil Steril 2002; 78 Suppl: S5.
Vajolerdi MR, Karimian L, Yazdi PE, Gilani MAS, Madani T, Baghestani AR. Efficcacy of a human embryo transfer medium: a prospective
randomised clinical trial study. J Assist Reprod Genet 2006; 23: 207–12.
Virant-Klun I, Tomaževič T, Požlep B, Vrtačnik Bokal E, Vogler A, Zorn B, et al. Pre-incubation of frozen-thawed blastocysts in hyaluronan
before the transfer increases pregnany rate. In: Guran T, Demirol A, eds. International proceedings: 13th world congress on in vitro
fertilization assisted reproduction and genetics. Istambul, Turkey, May 26–29 2005. Istanbul: Kenes international; 2005. p. 97–100.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
